相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Progress towards clinical xenotransplantation
Henk-Jan Schuurman et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors
Tanja Hakkarainen et al.
HUMAN GENE THERAPY (2007)
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies
H. T. Ong et al.
GENE THERAPY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity
Anthony T. Power et al.
MOLECULAR THERAPY (2007)
Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy
Ianko D. Iankov et al.
MOLECULAR THERAPY (2007)
Synergistic antitumor effects of immune cell-viral biotherapy
SH Thorne et al.
SCIENCE (2006)
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
S Komarova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells
C Cole et al.
NATURE MEDICINE (2005)
Targeted measles virus vector displaying echistatin infects endothelial cells via αvβ3 and leads to tumor regression
LK Hallak et al.
CANCER RESEARCH (2005)
Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors
J García-Castro et al.
CANCER GENE THERAPY (2005)
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection
K Morizono et al.
NATURE MEDICINE (2005)
Rescue and propagation of fully retargeted oncolytic measles viruses
T Nakamura et al.
NATURE BIOTECHNOLOGY (2005)
Preferential targeting of vesicular stomatitis virus to breast cancer cells
I Bergman et al.
VIROLOGY (2004)
Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases
Z Raykov et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker
KW Peng et al.
BLOOD (2003)
An oncolytic measles virus engineered to enter cells through the CD20 antigen
AD Bucheit et al.
MOLECULAR THERAPY (2003)
Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen
AL Hammond et al.
JOURNAL OF VIROLOGY (2001)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)